Mold-Tek Technologies Approves Preferential Issue of Equity Shares Worth ₹4.75 Crore
Mold-Tek Technologies approved a preferential issue of up to 2,90,000 equity shares at ₹164 each, aggregating ₹4.75 crore. An EGM is scheduled for March 30, 2026, to seek member approval. The issue is to identified investor Mr. Richard Leon Cannyn.
The preferential issue of ₹4.75 crore is a significant amount for the company and will likely impact its capital structure and potentially lead to dilution for existing shareholders. The appointment of an EGM also signifies a material corporate action.
The preferential issue of equity shares indicates a fundraising activity which is generally viewed positively as it can support business growth or expansion.
Mold-Tek Technologies Limited has announced the outcome of its Board Meeting held on February 28, 2026. The Board has approved the issuance of up to 2,90,000 equity shares of face value ₹2 each at an issue price of ₹164 per share, including a premium of ₹162 per share. This preferential issue, for cash to an identified investor (Non-Promoter), aggregates up to ₹4,75,60,000 (Rupees Four Crores Seventy-Five Lacs Sixty Thousand Only). The approval is subject to member approval and compliance with Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.
To facilitate this preferential issue, the company will convene an Extraordinary General Meeting (EGM) on Monday, March 30, 2026, at 11:30 AM IST. The EGM will be conducted through video conference/Other Audio Visual Means to seek member approval for the preferential allotment. Mr. Ashish Kumar Gaggar, a Company Secretary in Practice, has been appointed as the scrutinizer to oversee the entire e-voting process for the EGM.
The Relevant Date for the SEBI ICDR Regulations is February 27, 2026. The disclosure also specifies that Mr. Richard Leon Cannyn is the identified investor, who will hold 0.997% post-allotment, and the issue price is ₹164 per equity share.
What to do with a filing like this
Mold-Tek Technologies Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mold-Tek Technologies Limited. Read the original for the full detail.